Supernus Pharmaceuticals SUPN Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's gross margin?
- Supernus Pharmaceuticals (SUPN) reported gross margin of 89.4% in Q1 2026.
- How has Supernus Pharmaceuticals's gross margin changed year-over-year?
- Supernus Pharmaceuticals's gross margin increased by 1.1% year-over-year, from 88.4% to 89.4%.
- What is the long-term trend for Supernus Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's gross margin has grown at a -0.1% compound annual growth rate (CAGR), from 89.9% to 89.6%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.